Market Recap Check: AlloVir Inc (ALVR)’s Negative Finish at 0.46, Up/Down -8.91

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of AlloVir Inc (NASDAQ: ALVR) closed at $0.46 in the last session, down -8.91% from day before closing price of $0.50. In other words, the price has decreased by -$8.91 from its previous closing price. On the day, 0.56 million shares were traded. ALVR stock price reached its highest trading level at $0.4998 during the session, while it also had its lowest trading level at $0.45.

Ratios:

We take a closer look at ALVR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 86.78 and its Current Ratio is at 86.78. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on December 26, 2023, Downgraded its rating to Underperform and sets its target price to $1 from $17 previously.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 19 ’24 when Hagen Brett R sold 554 shares for $0.55 per share. The transaction valued at 304 led to the insider holds 68,506 shares of the business.

Sinha Vikas sold 3,186 shares of ALVR for $1,748 on Nov 19 ’24. The insider now owns 1,140,894 shares after completing the transaction at $0.55 per share. On Nov 19 ’24, another insider, Miller Edward, who serves as the General Counsel of the company, sold 432 shares for $0.55 each. As a result, the insider received 237 and left with 211,499 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALVR now has a Market Capitalization of 58361120 and an Enterprise Value of -58813416.

Stock Price History:

Over the past 52 weeks, ALVR has reached a high of $2.48, while it has fallen to a 52-week low of $0.48. The 50-Day Moving Average of the stock is -34.40%, while the 200-Day Moving Average is calculated to be -38.40%.

Shares Statistics:

According to the various share statistics, ALVR traded on average about 329.85K shares per day over the past 3-months and 275850 shares per day over the past 10 days. A total of 115.44M shares are outstanding, with a floating share count of 51.78M. Insiders hold about 55.19% of the company’s shares, while institutions hold 33.08% stake in the company. Shares short for ALVR as of 1730332800 were 3953471 with a Short Ratio of 5.83, compared to 1727654400 on 5503571. Therefore, it implies a Short% of Shares Outstanding of 3953471 and a Short% of Float of 6.34.

Earnings Estimates

The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$0.42 and -$0.42 for the fiscal current year, implying an average EPS of -$0.42. EPS for the following year is -$0.32, with 1.0 analysts recommending between -$0.32 and -$0.32.

Most Popular